OPR13 Antibody

Shipped with Ice Packs
In Stock

Description

Absence of "OPR13 Antibody" in Scientific Literature

The term "OPR13 Antibody" does not appear in any of the provided sources, including:

  • Peer-reviewed articles on recombinant antibodies ( ).

  • Antibody characterization initiatives (e.g., YCharOS, OGA) ( ).

  • Therapeutic antibody registries ( ).

  • Commercial antibody databases (e.g., Sigma-Aldrich’s Anti-OR13A1 antibody) ( ).

OR13A1 Antibody

The closest match is OR13A1, an olfactory receptor family member targeted by a commercial antibody ( ):

  • Product: Anti-OR13A1 antibody (Human Protein Atlas project).

  • Reactivity: Human-specific.

  • Applications: Immunohistochemistry (1:50–1:200 dilution) and immunofluorescence.

  • Immunogen: Synthetic peptide sequence YAYISPVSGYSAGKSKLAGL.

  • Validation: Tested against 44 normal human tissues and 20 cancer tissues.

Other Possibilities

  • OPR13 may refer to a hypothetical or obsolete designation not cataloged in current databases.

  • Potential typographical errors (e.g., "OPR" vs. "OR" for olfactory receptors).

Relevant Antibody Characterization Challenges

The lack of data underscores broader issues in antibody validation:

  • Reproducibility: Studies show ~50–75% of commercial antibodies fail validation in standardized assays ( ).

  • Recombinant Antibody Superiority: Engineered antibodies (e.g., Fc-modified variants) often outperform traditional monoclonals in specificity and renewable production ( ).

Recommendations for Further Research

If "OPR13" is critical to your work:

  1. Verify Nomenclature: Cross-check gene/protein databases (e.g., UniProt, NCBI) for alternate names.

  2. Explore Orthologs: Investigate homologous proteins in model organisms.

  3. Custom Antibody Development: Consider recombinant antibody engineering for novel targets ( ).

Key Data Table: Anti-OR13A1 Antibody (Closest Identified Product)

ParameterDetails
TargetOR13A1 (Olfactory Receptor 13A1)
Host SpeciesRabbit
ApplicationsImmunohistochemistry, Immunofluorescence
Validation44 normal tissues, 20 cancer tissues, protein arrays ( )
Commercial SourceSigma-Aldrich (Product Code: HPA057237)
Price$598.00/100 μL

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
OPR13 antibody; OPR9 antibody; Os04g0443801 antibody; OsJ_14925 antibody; Putative 12-oxophytodienoate reductase 13 antibody; EC 1.3.1.- antibody; OPDA-reductase 13 antibody; OsOPR13 antibody
Target Names
OPR13
Uniprot No.

Target Background

Function
Putative oxophytodienoate reductase that may be involved in the biosynthesis or metabolism of oxylipin signaling molecules.
Database Links
Protein Families
NADH:flavin oxidoreductase/NADH oxidase family

Q&A

What is the OPR13 antibody and what are its primary applications?

OPR13 antibody is a research reagent designed to specifically bind to the Putative 12-oxophytodienoate reductase 13 protein from rice (Oryza sativa subsp. japonica). This polyclonal antibody is typically generated in rabbits and purified using antigen-affinity methods .

Primary applications include:

  • Western Blot (WB) analysis for protein detection and quantification

  • Enzyme-Linked Immunosorbent Assay (ELISA) for sensitive antigen detection

  • Immunoprecipitation studies to isolate OPR13 from complex protein mixtures

When designing experiments with OPR13 antibody, researchers should consider the following methodology:

  • Start with optimization experiments using positive controls

  • Establish appropriate blocking conditions to minimize background

  • Determine optimal antibody dilution (typically starting with 1:1000 for WB and 1:500 for ELISA)

  • Include proper negative controls (secondary antibody only, pre-immune serum)

How should OPR13 antibody specificity be validated?

Antibody specificity is a critical consideration in research. For OPR13 antibody validation, implement the following methodological approach:

  • Compare multiple antibody sources: Test antibodies from different suppliers or production batches to confirm consistent binding profiles .

  • Perform epitope mapping: Identify the specific region(s) of OPR13 recognized by the antibody using peptide arrays or deletion mutants.

  • Cross-reactivity testing: Assess potential cross-reactivity with other OPR family members, particularly OPR9, which shares sequence similarity .

  • Knockout/knockdown validation: Use OPR13 knockout/knockdown samples as negative controls to confirm antibody specificity.

Validation MethodTechnical ApproachExpected Outcome for Specific Antibody
Western blotRun purified OPR13 alongside cell lysatesSingle band at expected molecular weight
ImmunoprecipitationPull-down followed by mass spectrometryOPR13 as primary identified protein
Cross-reactivity testingTest against OPR9 and other family membersMinimal binding to related proteins
Signal reduction testCompare signal in normal vs. OPR13-depleted samplesSignificant signal reduction in depleted samples

What are the optimal storage conditions for maintaining OPR13 antibody activity?

Proper storage is essential for maintaining antibody functionality. For OPR13 antibodies:

  • Short-term storage (up to 1 month): Store at 4°C with preservatives (typically 0.02% sodium azide).

  • Long-term storage: Aliquot and store at -20°C or -80°C to avoid freeze-thaw cycles, which can degrade antibody performance.

  • Working dilutions: Prepare fresh on the day of use, or store at 4°C for no more than 1 week.

  • Stability assessments: Periodically test antibody performance against reference standards to monitor potential degradation over time.

A systematic approach to antibody storage validation includes testing activity after different storage conditions and time periods, and documenting the results to establish optimal protocols for your specific research applications.

How does antigen expression level affect OPR13 antibody penetration in plant tissue samples?

The efficacy of OPR13 antibody in plant tissue is significantly influenced by antigen expression levels and turnover rates. Mathematical models of antibody transport predict that these factors are critical determinants of penetration .

When working with plant tissues expressing OPR13:

  • Consider fixation methods: Different fixation protocols affect epitope accessibility. For OPR13 detection in rice tissues, compare cross-linking fixatives (paraformaldehyde) with precipitating fixatives (acetone) to determine optimal preservation of antigen recognition.

  • Tissue penetration strategies: For thicker sections or whole-mount preparations, implement extended incubation times (24-48 hours) at 4°C and include detergents (0.1-0.3% Triton X-100) to enhance antibody penetration.

  • Antigen retrieval optimization: Test multiple antigen retrieval methods (heat-induced, enzymatic, pH-based) to maximize epitope exposure without causing tissue damage.

Research demonstrates that antibody penetration is inversely related to antigen expression level and turnover rate, with mathematical models suggesting that targets with lower expression and slower internalization rates allow for better tissue penetration . When designing immunohistochemistry experiments with OPR13 antibody, consider these parameters and adjust protocols accordingly.

What strategies can improve OPR13 antibody specificity for distinguishing between closely related OPR family proteins?

Distinguishing between closely related proteins like OPR13 and OPR9 presents significant challenges. Recent research in antibody engineering and selection provides innovative approaches:

  • Biophysics-informed modeling approach: Recent advances utilize phage display experiments to select antibodies against combinations of closely related ligands. This approach associates each potential ligand with a distinct binding mode and enables prediction and generation of specific variants beyond those observed in experiments .

  • Disentangling multiple binding modes: When OPR13 and OPR9 share epitopes, computational analysis can identify different binding modes associated with particular ligands, even when these epitopes are chemically very similar .

  • Custom specificity profile design: Create antibody variants with predefined binding profiles, either cross-specific (interacting with several distinct ligands) or highly specific (interacting with a single ligand while excluding others) .

For experimental validation of specificity:

ApproachMethodologyApplication to OPR13/OPR9 Discrimination
Competitive binding assaysPre-incubate antibody with purified OPR9 before OPR13 detectionReduction in signal indicates cross-reactivity
Epitope mappingIdentify unique vs. shared epitopes between OPR13 and OPR9Target antibody production to unique regions
Affinity measurementsSurface Plasmon Resonance to determine binding constantsSelect antibodies with >10× higher affinity for OPR13
Computational designModel-guided antibody engineeringGenerate variants with customized specificity profiles

How can combinations of OPR13 antibodies be optimized for enhanced detection sensitivity and specificity?

Combination approaches using multiple antibodies can significantly improve detection parameters. Research on antibody combinations demonstrates enhanced efficacy compared to single antibody applications .

Methodological approach:

  • Epitope mapping combinations: Select antibodies that target different epitopes on OPR13 to increase avidity and reduce the probability of false negatives due to epitope masking or modification.

  • Sandwich ELISA optimization: When one antibody is used for capture and another for detection, systematically test different antibody pairs to identify combinations that maximize signal-to-noise ratio.

  • Signal amplification strategies: Implement systems such as:

    • Biotin-streptavidin enhancement

    • Tyramide signal amplification

    • Polymer-based detection systems

  • Validation across multiple detection platforms: Test antibody combinations across different applications (WB, ELISA, IHC) to ensure consistent performance.

Research data suggests that combining two high-affinity antibodies can achieve sensitivity improvements of 10-100 fold compared to individual antibodies, while simultaneously reducing background and cross-reactivity issues .

What considerations are important when using OPR13 antibodies for quantitative analysis of protein expression across different rice varieties?

Quantitative analysis using OPR13 antibodies requires careful experimental design and standardization:

  • Reference standard development: Generate purified recombinant OPR13 at >85% purity as determined by SDS-PAGE to create calibration curves.

  • Internal loading controls: Select appropriate housekeeping proteins that maintain stable expression across different rice varieties.

  • Normalization strategies: Implement multiple normalization approaches:

    • Total protein normalization (Ponceau S, SYPRO Ruby)

    • Housekeeping protein normalization (actin, tubulin)

    • Spike-in controls for absolute quantification

  • Technical validation: Assess technical parameters including:

    • Linear dynamic range determination

    • Limit of detection/quantification

    • Inter-assay and intra-assay variability

    • Recovery rates in complex matrices

Analytical ParameterRecommended MethodExpected Performance Metrics
Linear dynamic rangeSerial dilution seriesAt least 2 orders of magnitude
Limit of detectionSignal-to-noise ratio >3:1Typically 0.1-1 ng/mL for ELISA
ReproducibilityCoefficient of variation (CV)CV <15% for intra-assay, <20% for inter-assay
RecoverySpike-in of known amounts80-120% recovery

What are common sources of background in OPR13 antibody experiments and how can they be minimized?

High background is a frequent challenge in antibody-based experiments. For OPR13 antibody applications, consider these methodological solutions:

  • Blocking optimization: Systematically test different blocking agents (BSA, casein, non-fat dry milk, commercial blocking buffers) at various concentrations (1-5%) to identify optimal conditions.

  • Cross-reactivity reduction: Pre-adsorb antibodies with plant extracts lacking OPR13 to remove antibodies that bind to common plant epitopes.

  • Secondary antibody selection: Choose secondary antibodies with minimal cross-reactivity to plant proteins and pre-test through negative controls.

  • Sample preparation refinement: Implement additional purification steps to remove interfering compounds:

    • TCA/acetone precipitation for removing phenolic compounds

    • PVPP treatment to remove polyphenols

    • Protein fractionation to enrich for OPR13

Most background issues stem from non-specific binding or cross-reactivity. By systematically optimizing each protocol step and including appropriate controls, researchers can achieve optimal signal-to-noise ratios.

How should researchers address epitope masking issues when detecting OPR13 in complex plant tissues?

Epitope masking can significantly impact antibody recognition of OPR13 in complex samples. Address this challenge through:

  • Multiple extraction methods comparison: Test different protein extraction buffers that vary in:

    • Detergent type and concentration (RIPA, NP-40, Triton X-100)

    • Denaturing agents (urea, SDS)

    • Salt concentration

    • pH conditions

  • Antigen retrieval matrix: For fixed tissues, systematically test combinations of:

    • Heat-induced epitope retrieval at different temperatures (80-120°C)

    • pH ranges (citrate pH 6.0, EDTA pH 8.0, Tris pH 9.0)

    • Incubation times (10-30 minutes)

  • Enzymatic treatments: Apply proteolytic enzymes (proteinase K, trypsin) at carefully optimized concentrations and incubation times to expose hidden epitopes.

  • Alternative antibody formats: Test F(ab) fragments or single-chain variable fragments that may access epitopes better due to smaller size.

Systematic documentation of these optimization efforts will establish reliable protocols for consistent OPR13 detection across different experimental conditions.

How can OPR13 antibodies be effectively used to study protein-protein interactions in jasmonate signaling pathways?

OPR13's role in jasmonate biosynthesis makes protein interaction studies particularly valuable. Implement these methodological approaches:

  • Co-immunoprecipitation (Co-IP) optimization:

    • Use gentle lysis buffers to preserve protein complexes

    • Compare different antibody immobilization strategies (direct coupling, Protein A/G)

    • Include appropriate controls (IgG control, reverse Co-IP)

    • Validate interactions through reciprocal pull-downs

  • Proximity ligation assay (PLA) implementation:

    • Optimize fixation conditions to preserve protein complexes while maintaining epitope accessibility

    • Determine optimal antibody dilutions through titration experiments

    • Include specificity controls (single antibody controls, competing peptides)

  • Bimolecular Fluorescence Complementation (BiFC):

    • Design fusion constructs that maintain OPR13 functionality

    • Validate expression and localization of fusion proteins

    • Include appropriate negative controls (non-interacting protein pairs)

Interaction MethodKey AdvantagesTechnical Considerations
Co-IPDetects native complexesRequires optimization of buffer conditions
PLAHigh sensitivity for in situ detectionRequires two antibodies against different proteins
BiFCDirect visualization in living cellsPotential for artifacts due to overexpression
FRET/FLIMCan measure interaction dynamicsRequires specialized equipment and expertise

What considerations are important when using OPR13 antibodies for comparative studies across different plant stress conditions?

Stress-induced changes in protein expression, modification, and localization require careful experimental design:

  • Standardized stress application protocols:

    • Define precise parameters for each stress condition (duration, intensity)

    • Implement consistent growth conditions before stress application

    • Include appropriate recovery time points

  • Sampling strategy optimization:

    • Establish time-course experiments covering early, intermediate, and late responses

    • Consider tissue-specific responses (roots, leaves, reproductive tissues)

    • Implement consistent harvesting protocols to minimize variability

  • Multi-level analysis approach:

    • Combine protein abundance measurements (Western blot, ELISA)

    • Assess post-translational modifications (phosphorylation, ubiquitination)

    • Determine subcellular localization changes (fractionation, immunolocalization)

  • Statistical design considerations:

    • Determine appropriate sample sizes through power analysis

    • Implement randomization strategies to minimize systematic errors

    • Include biological and technical replicates

By systematically addressing these considerations, researchers can generate reliable comparative data on OPR13 dynamics across different stress conditions, providing insights into jasmonate signaling pathway regulation.

How might emerging antibody engineering technologies enhance OPR13 research applications?

Recent advances in antibody technology offer promising approaches for OPR13 research:

  • Biophysics-informed modeling: This approach enables the design of antibodies with customized specificity profiles, including either specific high affinity for OPR13 or cross-specificity for multiple OPR family members .

  • Half-life extension modifications: Techniques similar to those used in therapeutic antibodies (C135-LS and C144-LS) could create research antibodies with extended stability for long-term experiments .

  • Single-domain antibodies (nanobodies): These smaller antibody fragments may offer superior tissue penetration for complex plant samples, addressing limitations identified in mathematical models of antibody transport .

  • Recombinant antibody fragments: Expressing just the variable domains or single-chain variable fragments could improve epitope access in densely packed plant tissues.

Future research directions should explore how these emerging technologies can be applied to create next-generation OPR13 antibodies with enhanced specificity, sensitivity, and application versatility.

What methodological advances could improve quantitative analysis of OPR13 in complex plant samples?

Emerging methodologies hold promise for enhancing OPR13 quantification:

  • Mass spectrometry-based approaches:

    • Targeted proteomics using selected reaction monitoring (SRM)

    • Development of isotopically labeled standard peptides for absolute quantification

    • Data-independent acquisition methods for improved reproducibility

  • Digital ELISA technologies:

    • Single-molecule array (Simoa) technology for ultra-sensitive detection

    • Adaptation of proximity extension assays for plant protein research

    • Microfluidic-based digital immunoassays for higher throughput

  • Integrated multi-omics approaches:

    • Correlating protein abundance with transcript levels

    • Integrating metabolomics data on jasmonate pathway intermediates

    • Combining with phosphoproteomics for functional activity assessment

Emerging TechnologyPotential AdvantageCurrent Limitations
Targeted proteomicsAbsolute quantificationRequires specialized equipment
Digital ELISAUltra-high sensitivityLimited commercial availability for plant research
Single-cell proteomicsCell-type specific analysisTechnical challenges in plant cell isolation
Spatial proteomicsTissue localization contextMethod development needed for plant tissues

By adopting these methodological advances, researchers can achieve more precise quantification of OPR13 in complex plant samples, enabling deeper insights into its role in jasmonate signaling and plant stress responses.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.